Tag: nuclear medicine industry

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Nuclear Medicine Market Revenue Outlook: What CAGR Is Expected Through 2030?

The nuclear medicine sector has experienced substantial expansion lately, with projections indicating continued robust growth. This market, valued at $10.18 billion in 2025, is anticipated to reach $11.4 billion by 2026, reflecting a compound annual growth rate of 11.9%. Historically, factors such as constrained availability of nuclear imaging apparatus, elevated expenses associated with radiopharmaceuticals, a deficiency in skilled professionals, underdeveloped infrastructure within hospitals and diagnostic facilities, and diminished public awareness have hampered market penetration.

The nuclear medicine sector is poised for substantial expansion in the coming years, with projections indicating a market value of $17.13 billion by 2030, driven by a compound annual growth rate of 10.7%. This anticipated growth stems from a confluence of factors, including an escalating need for sophisticated diagnostic and therapeutic interventions, augmented governmental support for cancer and cardiovascular health initiatives, a broader integration of nuclear medicine within hospitals and diagnostic facilities, ongoing technological innovations in radiopharmaceuticals and imaging modalities, and an upward trend in patient awareness coupled with increased healthcare spending. Key developments anticipated during this forecast period involve a greater uptake of diagnostic imaging techniques, expanded utilization of therapeutic radiopharmaceuticals, heightened demand for PET and SPECT scans, a pronounced emphasis on applications within oncology and cardiology, and a progressive implementation across healthcare settings like hospitals and specialized diagnostic centers.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7485&type=smp

Nuclear Medicine Market Growth Drivers: What Factors Are Accelerating Expansion?

Anticipated advancements in the nuclear medicine market will be significantly influenced by the escalating rates and occurrence of cardiovascular ailments and malignant growths. These conditions, encompassing heart and circulatory system issues (cardiovascular diseases) and the uncontrolled proliferation and dissemination of aberrant cells (cancer), are becoming more widespread. Nuclear medicine techniques offer substantial benefits, such as expedited diagnosis of cardiac conditions through nuclear cardiac imaging, and effective treatment strategies for cancer, which can be administered alongside or following conventional approaches like surgery and chemotherapy. Consequently, the increasing incidence and prevalence of both cardiovascular diseases and cancer are directly stimulating demand within the nuclear medicine sector. To illustrate, the American Cancer Society Inc., a non-profit health organization in the USA, projected in January 2023 that approximately 1,958,310 new cancer diagnoses would occur in the United States, marking an upward trend from the over 1,918,030 cases identified in 2022. This heightened prevalence of cardiovascular diseases and cancer underscores the market’s upward trajectory.

Nuclear Medicine Market Segment Analysis Highlighting Growth Areas

The nuclear medicine market covered in this report is segmented –

1) By Type: Diagnostic, Therapeutic

2) By Application: Cardiology, Lymphoma, Thyroid, Neurology, Oncology, Other Applications

3) By End-User: Hospitals And Clinics, Diagnostic Centers, Other End-Users

Subsegments:

1) By Diagnostic: Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Gamma Cameras

2) By Therapeutic: Radiopharmaceuticals For Targeted Therapy, Beta Emitters, Alpha Emitters, Radiosynovectomy Agents

Nuclear Medicine Market Trends: What Is Shaping Future Industry Growth?

Key players within the nuclear medicine sector are actively pursuing the creation of groundbreaking technologies, including advanced cyclotrons, to optimize radiopharmaceutical manufacturing and elevate diagnostic imaging quality. Cyclotrons, functioning as sophisticated particle accelerators, are instrumental in generating the radioactive isotopes essential for both medical visualization and therapeutic interventions. They achieve this by bombarding target substances with highly energetic particles, thereby facilitating the creation of radiopharmaceuticals vital for diagnostic techniques like positron emission tomography (PET). Illustrating this trend, GE Healthcare China, a prominent US-based entity in the medical technology sphere, successfully initiated the production of its initial cyclotrons on December 1, 2023, within the Chengdu Tianfu International Bio-Town, marking a significant development in January 2024. The deployment of these cutting-edge accelerators is fundamentally important to the field of nuclear medicine, as they are indispensable for producing the medical isotopes that underpin molecular imaging and various therapeutic applications, ultimately fostering a robust nuclear medicine infrastructure designed to improve early disease identification and the delivery of tailored treatments.

Nuclear Medicine Market Leading Companies: Who Holds Significant Market Presence?

Major companies operating in the nuclear medicine market are Bracco Imaging S.P.A., Lantheus Medical Imaging Inc., NTP Radioisotopes SOC Ltd., Eckert & Ziegler Group, Jubilant Pharma LLC, Australian Nuclear Science & Technology Organisation, Cardinal Health Inc., GE Healthcare Technologies Inc., Curium Pharma, Advanced Accelerator Applications USA Inc., Nordion Inc., The Institute for Radioelements, Eczacibasi-Monrol Nuclear Products Co., Siemens Healthineers AG, Cambridge Isotope Laboratories Inc., Bayer AG, Triad Isotopes Inc., Mallinckrodt Pharmaceuticals plc, PharmaLogic Holdings Corp., Institute of Isotopes Co. Ltd., Sinotau Pharmaceuticals Limited, Isotopia Molecular Imaging Limited, SHINE Medical Technologies Inc., JSC Isotope Inc., NorthStar Medical Radioisotopes LLC, Global Medical Solutions LLC

Access The Complete Nuclear Medicine Market Report:

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-global-market-report

Nuclear Medicine Market Regional Analysis: Which Region Leads By Revenue?

North Americawas the largest region in the nuclear medicine market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the nuclear medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Nuclear Medicine Market’s Market Value Anticipated To Evolve From 2026 To 2030?

The rapid expansion of the nuclear medicine market has been observed in recent years. It is projected to increase from $10.18 billion in 2025 to $11.4 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.9%. The growth experienced in the historic period can be ascribed to factors such as limited access to nuclear imaging equipment, the high cost of radiopharmaceuticals, a lack of trained personnel, restricted hospital and diagnostic center infrastructure, and low patient awareness.

The nuclear medicine market is projected to experience substantial expansion over the upcoming years, reaching a valuation of $17.13 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.7%. This anticipated expansion throughout the forecast period stems from factors such as a heightened need for sophisticated diagnostic and therapeutic methods, growing governmental efforts in cancer and cardiac treatment, wider implementation in hospitals and diagnostic centers, breakthroughs in radiopharmaceuticals and imaging technology, and greater patient knowledge coupled with increased healthcare spending. Key developments expected during this period encompass a greater acceptance of diagnostic imaging approaches, expanded application of therapeutic radiopharmaceuticals, heightened call for PET and SPECT scans, intensified concentration on oncology and cardiology uses, and more widespread deployment within hospitals and diagnostic facilities.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7485&type=smp

What Important Drivers Are Powering The Nuclear Medicine Market Growth?

The rising persistence and occurrence of cardiovascular disease (CVD) and cancer are projected to fuel the expansion of the nuclear medicine market. Cardiovascular diseases (CVDs) encompass various heart and blood vessel conditions, while cancer involves the uncontrolled proliferation of cells that can spread throughout the body. Nuclear cardiac imaging offers a rapid means for diagnosing heart ailments. Furthermore, nuclear medicine therapy provides a treatment approach for cancer, potentially used in conjunction with or following other treatments like surgery and chemotherapy. Consequently, the increasing persistence and occurrence of cardiovascular disease and cancer amplify the need for the nuclear medicine market. For example, in January 2023, the American Cancer Society Inc., a US-based non-profit health group, reported an estimated 1,958,310 new cancer cases to be diagnosed in the US, marking an increase from over 1,918,030 new cancer cases in 2022. Thus, the growing persistence and prevalence of cardiovascular diseases and cancer are propelling the nuclear medicine market.

What Segment Categories Are Evaluated In The Nuclear Medicine Market Study?

The nuclear medicine market covered in this report is segmented –

1) By Type: Diagnostic, Therapeutic

2) By Application: Cardiology, Lymphoma, Thyroid, Neurology, Oncology, Other Applications

3) By End-User: Hospitals And Clinics, Diagnostic Centers, Other End-Users

Subsegments:

1) By Diagnostic: Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Gamma Cameras

2) By Therapeutic: Radiopharmaceuticals For Targeted Therapy, Beta Emitters, Alpha Emitters, Radiosynovectomy Agents

Which Trends Are Influencing The Expansion Of The Nuclear Medicine Market?

Leading companies in the nootropics market are actively developing nootropics with multiple flavors, often as product line extensions within the nutraceutical sector, to bolster cognitive and physical health. A product line extension in nutraceuticals signifies a strategy where a firm introduces a new product or a variation within its existing health-focused brand collection, specifically in the nutraceutical domain, to address additional consumer requirements or broaden the spectrum of benefits. For example, in June 2023, Rollagranola, a food and beverage enterprise based in the UK, unveiled its Nootropics range, featuring four distinct flavors designed to satisfy both nutritional needs and taste preferences. This innovative collection includes Calm, Energize, Body and Soul, and Complete Vegan. Calm is formulated to encourage relaxation and alleviate stress, utilizing ingredients such as ashwagandha and matcha green tea. Energize provides a cappuccino and white chocolate blend aimed at improving focus and boosting energy, incorporating lion’s mane, caffeine, and panax ginseng. Body and Soul unites summer berries and walnuts to support overall physical and mental well-being, containing ingredients like creatine, maca, ginkgo, and panax ginseng. Lastly, Complete Vegan is a granola specifically crafted for vegans, supplying essential nutrients, pea protein, and key vitamins to mitigate deficiencies and enhance focus, memory, and mood.

Which Firms Are Competing In The Nuclear Medicine Market?

Major companies operating in the nuclear medicine market are Bracco Imaging S.P.A., Lantheus Medical Imaging Inc., NTP Radioisotopes SOC Ltd., Eckert & Ziegler Group, Jubilant Pharma LLC, Australian Nuclear Science & Technology Organisation, Cardinal Health Inc., GE Healthcare Technologies Inc., Curium Pharma, Advanced Accelerator Applications USA Inc., Nordion Inc., The Institute for Radioelements, Eczacibasi-Monrol Nuclear Products Co., Siemens Healthineers AG, Cambridge Isotope Laboratories Inc., Bayer AG, Triad Isotopes Inc., Mallinckrodt Pharmaceuticals plc, PharmaLogic Holdings Corp., Institute of Isotopes Co. Ltd., Sinotau Pharmaceuticals Limited, Isotopia Molecular Imaging Limited, SHINE Medical Technologies Inc., JSC Isotope Inc., NorthStar Medical Radioisotopes LLC, Global Medical Solutions LLC

Access The Complete Nuclear Medicine Market Report:

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-global-market-report

Which Geographic Region Represents The Largest Nuclear Medicine Market Share?

North America was the largest region in the nuclear medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nuclear medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Nuclear Medicine Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=7485&type=smp

Browse Through More Reports Similar to the Global Nuclear Medicine Market 2026, By The Business Research Company

Inotropic Agents Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/inotropic-agents-global-market-report

Orthobiologics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/orthobiologics-global-market-report

Spatial Omics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/spatial-omics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Nuclear Medicine Market Expected To Change From 2026 To 2030?

The nuclear medicine market has observed significant expansion in recent years. Its value is projected to rise from $10.18 billion in 2025 to $11.4 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.9%. This historical growth can be linked to factors such as limited access to nuclear imaging equipment, the high cost of radiopharmaceuticals, a shortage of trained personnel, constrained hospital and diagnostic center infrastructure, and low patient awareness.

The nuclear medicine market is projected to experience substantial expansion in the coming years, with its valuation anticipated to reach $17.13 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.7%. This projected growth during the forecast period stems from several factors, including a heightened demand for advanced diagnostic and therapeutic interventions, increased governmental efforts towards cancer and cardiac treatment, greater adoption within hospitals and diagnostic centers, innovations in radiopharmaceuticals and imaging technologies, and a rise in both patient awareness and overall healthcare spending. Key trends identified for this period encompass a wider embrace of diagnostic imaging methods, an expanded application of therapeutic radiopharmaceuticals, a surging requirement for PET and SPECT scans, an intensified concentration on oncology and cardiology uses, and broader deployment in healthcare facilities and diagnostic centers.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7485&type=smp

What Key Drivers Are Fueling The Growth Of The Nuclear Medicine Market?

The expanding regularity and widespread occurrence of cardiovascular disease (CVD) and cancer are anticipated to drive the expansion of the nuclear medicine market in the future. Cardiovascular diseases (CVDs) encompass various conditions affecting the heart and blood vessels, while cancer involves the uncontrolled proliferation and dissemination of cells throughout the body. Nuclear cardiac imaging offers a faster diagnosis for heart conditions, and nuclear medicine therapy presents a treatment approach for cancer, potentially employed alongside or following other therapeutic interventions like surgery and chemotherapy. Consequently, the increasing incidence and prevalence of cardiovascular disease and cancer fuel the demand within the nuclear medicine market. For instance, the American Cancer Society Inc., a non-profit health organization based in the US, reported that in January 2023, an estimated 1,958,310 new cancer cases were projected for diagnosis in the US. This figure indicates an increase from over 1,918,030 new cancer cases reported in 2022. Hence, the rising frequency and widespread occurrence of cardiovascular diseases and cancer are key drivers for the nuclear medicine market.

How Are Segments Identified Within The Nuclear Medicine Market Segment Framework?

The nuclear medicine market covered in this report is segmented –

1) By Type: Diagnostic, Therapeutic

2) By Application: Cardiology, Lymphoma, Thyroid, Neurology, Oncology, Other Applications

3) By End-User: Hospitals And Clinics, Diagnostic Centers, Other End-Users

Subsegments:

1) By Diagnostic: Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Gamma Cameras

2) By Therapeutic: Radiopharmaceuticals For Targeted Therapy, Beta Emitters, Alpha Emitters, Radiosynovectomy Agents

What Trends Are Influencing The Nuclear Medicine Market?

Leading entities within the nuclear medicine sector are prioritizing the creation of novel solutions, including nuclear medicine cyclotrons, to boost the output of radiopharmaceuticals and refine diagnostic imaging potential. These cyclotrons are specialized accelerators of particles designed to generate radioactive isotopes for use in medical imaging and therapy. They achieve this by firing high-energy particles at specific materials, which allows for the creation of radiopharmaceuticals utilized in processes such as positron emission tomography (PET). As an illustration, in January 2024, GE Healthcare China, a medical technology firm based in the US, introduced its initial set of cyclotrons on December 1, 2023, situated at the Chengdu Tianfu International Bio-Town. Such sophisticated particle accelerators play a vital role in nuclear medicine, facilitating the manufacture of medical isotopes applied in molecular imaging and various therapeutic uses. The goal of this endeavor is to construct an all-encompassing nuclear medicine ecosystem, thereby elevating capacities for early detection of diseases and individualized treatment approaches.

Who Are The Companies Competing Within The Nuclear Medicine Market?

Major companies operating in the nuclear medicine market are Bracco Imaging S.P.A., Lantheus Medical Imaging Inc., NTP Radioisotopes SOC Ltd., Eckert & Ziegler Group, Jubilant Pharma LLC, Australian Nuclear Science & Technology Organisation, Cardinal Health Inc., GE Healthcare Technologies Inc., Curium Pharma, Advanced Accelerator Applications USA Inc., Nordion Inc., The Institute for Radioelements, Eczacibasi-Monrol Nuclear Products Co., Siemens Healthineers AG, Cambridge Isotope Laboratories Inc., Bayer AG, Triad Isotopes Inc., Mallinckrodt Pharmaceuticals plc, PharmaLogic Holdings Corp., Institute of Isotopes Co. Ltd., Sinotau Pharmaceuticals Limited, Isotopia Molecular Imaging Limited, SHINE Medical Technologies Inc., JSC Isotope Inc., NorthStar Medical Radioisotopes LLC, Global Medical Solutions LLC

Get The Full Nuclear Medicine Market Report:

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-global-market-report

Which Region Is The Top Contributor To The Nuclear Medicine Market By Share?

North America was the largest region in the nuclear medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nuclear medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Nuclear Medicine Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-global-market-report

Browse Through More Reports Similar to the Global Nuclear Medicine Market 2026, By The Business Research Company

Inotropic Agents Market Report 2026

https://www.thebusinessresearchcompany.com/report/inotropic-agents-global-market-report

Orthobiologics Market Report

https://www.thebusinessresearchcompany.com/report/orthobiologics-global-market-report

Spatial Omics Market Report

https://www.thebusinessresearchcompany.com/report/spatial-omics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Nuclear Medicine Market At The End Of The 2026–2030 Forecast Period?

The nuclear medicine market has experienced substantial expansion in recent years. It is projected to increase from $10.18 billion in 2025 to $11.4 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.9%. During the historic period, this growth was influenced by factors including restricted access to nuclear imaging equipment, the high cost of radiopharmaceuticals, a shortage of trained personnel, limited hospital and diagnostic center infrastructure, and low patient awareness.

The nuclear medicine market is projected for significant expansion over the upcoming years. Its valuation is anticipated to reach $17.13 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.7%. This expansion during the projected period stems from several factors, including an escalating need for sophisticated diagnostic and therapeutic methods, growing governmental efforts in cancer and cardiac treatment, wider integration into hospitals and diagnostic facilities, innovations in radiopharmaceuticals and imaging technologies, and enhanced patient understanding coupled with higher healthcare spending. Key developments expected within this period encompass a greater acceptance of diagnostic imaging approaches, expanded application of therapeutic radiopharmaceuticals, a surge in the requirement for PET and SPECT scans, intensified concentration on oncology and cardiology applications, and broader deployment across hospitals and diagnostic centers.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7485&type=smp

What Primary Drivers Are Shaping The Development Of The Nuclear Medicine Market?

The rising consistency and widespread occurrence of cardiovascular disease (CVD) and cancer are projected to stimulate the expansion of the nuclear medicine market in the future. Cardiovascular diseases (CVDs) encompass various heart and blood vessel conditions, while cancer involves cells multiplying uncontrollably and spreading throughout the body. Nuclear cardiac imaging offers a faster method for diagnosing heart-related illnesses. Additionally, nuclear medicine therapy provides a cancer treatment approach that can be employed either alongside or following other therapeutic interventions, including surgery and chemotherapy. Consequently, the increasing consistency and prevalence of cardiovascular disease and cancer heighten the demand for the nuclear medicine market. For instance, in January 2023, the American Cancer Society Inc., a US-based non-profit health organization, projected 1,958,310 new cancer diagnoses in the US, which represents an increase from over 1,918,030 new cancer cases recorded in 2022. Thus, the rising constancy and prevalence of cardiovascular diseases and cancer are serving as key drivers for the nuclear medicine market.

What Segment Types Make Up The Nuclear Medicine Market?

The nuclear medicine market covered in this report is segmented –

1) By Type: Diagnostic, Therapeutic

2) By Application: Cardiology, Lymphoma, Thyroid, Neurology, Oncology, Other Applications

3) By End-User: Hospitals And Clinics, Diagnostic Centers, Other End-Users

Subsegments:

1) By Diagnostic: Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Gamma Cameras

2) By Therapeutic: Radiopharmaceuticals For Targeted Therapy, Beta Emitters, Alpha Emitters, Radiosynovectomy Agents

Which Market Trends Are Creating New Opportunities In The Nuclear Medicine Market?

Leading companies active in the nuclear medicine market are focused on developing innovative solutions, including nuclear medicine cyclotrons, to boost the production of radiopharmaceuticals and enhance diagnostic imaging capabilities. Nuclear medicine Cyclotrons are specialized particle accelerators that create radioactive isotopes for medical imaging and therapy by directing high-energy particles at target materials, enabling the synthesis of radiopharmaceuticals utilized in procedures such as positron emission tomography (PET). For instance, in January 2024, GE Healthcare China, a US-based medical technology company, launched its inaugural batch of cyclotrons on December 1, 2023, at the Chengdu Tianfu International Bio-Town. These advanced particle accelerators are vital for nuclear medicine, facilitating the production of medical isotopes used in molecular imaging and therapeutic applications. This initiative aims to establish a comprehensive ecosystem for nuclear medicine, thereby improving capabilities in early disease detection and personalized treatment.

Who Are The Key Players Driving Competition In The Nuclear Medicine Market?

Major companies operating in the nuclear medicine market are Bracco Imaging S.P.A., Lantheus Medical Imaging Inc., NTP Radioisotopes SOC Ltd., Eckert & Ziegler Group, Jubilant Pharma LLC, Australian Nuclear Science & Technology Organisation, Cardinal Health Inc., GE Healthcare Technologies Inc., Curium Pharma, Advanced Accelerator Applications USA Inc., Nordion Inc., The Institute for Radioelements, Eczacibasi-Monrol Nuclear Products Co., Siemens Healthineers AG, Cambridge Isotope Laboratories Inc., Bayer AG, Triad Isotopes Inc., Mallinckrodt Pharmaceuticals plc, PharmaLogic Holdings Corp., Institute of Isotopes Co. Ltd., Sinotau Pharmaceuticals Limited, Isotopia Molecular Imaging Limited, SHINE Medical Technologies Inc., JSC Isotope Inc., NorthStar Medical Radioisotopes LLC, Global Medical Solutions LLC

Read the full nuclear medicine market report here:

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-global-market-report

How Does The Nuclear Medicine Market Perform Across Major Global Regions?

North America was the largest region in the nuclear medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nuclear medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Nuclear Medicine Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7485&type=smp

Browse Through More Reports Similar to the Global Nuclear Medicine Market 2026, By The Business Research Company

Inotropic Agents Global Market Report

https://www.thebusinessresearchcompany.com/report/inotropic-agents-global-market-report

Orthobiologics Global Market Report

https://www.thebusinessresearchcompany.com/report/orthobiologics-global-market-report

Spatial Omics Global Market Report

https://www.thebusinessresearchcompany.com/report/spatial-omics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the nuclear medicine market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Nuclear Medicine Market between 2026 and 2030?

The size of the nuclear medicine market has expanded quickly in recent years. It is projected to grow from $10.18 billion in 2025 to $11.4 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.9%. Historically, this growth has been ascribed to factors including restricted access to nuclear imaging equipment, the high expense of radiopharmaceuticals, a scarcity of trained personnel, underdeveloped hospital and diagnostic center infrastructure, and insufficient patient awareness.

The nuclear medicine market is anticipated to experience substantial expansion over the next few years. It is projected to reach $17.13 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.7%. This growth during the forecast period is propelled by several factors, including a surging demand for advanced diagnostic and therapeutic methods, expanding government initiatives in cancer and cardiac care, increased uptake by hospitals and diagnostic centers, technological innovations in radiopharmaceuticals and imaging, and rising patient awareness alongside increased healthcare expenditure. Prominent trends expected in this timeframe encompass the wider adoption of diagnostic imaging techniques, increased utilization of therapeutic radiopharmaceuticals, a growing need for PET and SPECT scans, a heightened focus on oncology and cardiology applications, and broader implementation across hospitals and diagnostic facilities.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7485&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Nuclear Medicine Market?

The rising constancy and prevalence of cardiovascular disease (CVD) and cancer are projected to drive the future growth of the nuclear medicine market. CVDs are disorders affecting the heart and blood vessels, while cancer is characterized by cells multiplying uncontrollably and spreading to other body parts. Nuclear cardiac imaging provides a quicker way to diagnose cardiac diseases. Furthermore, nuclear medicine therapy offers a treatment option for cancer, potentially utilized alongside or after other therapies such as surgery and chemotherapy. Consequently, the increasing constancy and prevalence of cardiovascular disease and cancer are boosting the demand for the nuclear medicine market. For instance, in January 2023, the American Cancer Society Inc., a US-based non-profit health group, anticipated 1,958,310 new cancer cases to be diagnosed in the US, which marks an increase compared to more than 1,918,030 new cancer cases in 2022. Hence, the escalating constancy and prevalence of cardiovascular diseases and cancer are actively propelling the nuclear medicine market.

What Segments Are Included Within The Nuclear Medicine Market?

The nuclear medicine market covered in this report is segmented –

1) By Type: Diagnostic, Therapeutic

2) By Application: Cardiology, Lymphoma, Thyroid, Neurology, Oncology, Other Applications

3) By End-User: Hospitals And Clinics, Diagnostic Centers, Other End-Users

Subsegments:

1) By Diagnostic: Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Gamma Cameras

2) By Therapeutic: Radiopharmaceuticals For Targeted Therapy, Beta Emitters, Alpha Emitters, Radiosynovectomy Agents

Which Trends Are Expected To Influence The Nuclear Medicine Market In The Upcoming Years?

Major companies operating in the nuclear medicine market are focusing on developing innovative solutions, including nuclear medicine cyclotrons, to enhance the production of radiopharmaceuticals and refine diagnostic imaging capabilities. Nuclear medicine cyclotrons are specialized particle accelerators that produce radioactive isotopes for medical imaging and therapy by directing high-energy particles at target materials, enabling the synthesis of radiopharmaceuticals utilized in procedures like positron emission tomography (PET). For instance, in January 2024, GE Healthcare China, a US-based medical technology company, initiated the launch of its first batch of cyclotrons on December 1, 2023, at the Chengdu Tianfu International Bio-Town. These advanced particle accelerators are crucial for nuclear medicine, allowing for the production of medical isotopes used in molecular imaging and therapeutic applications. This initiative aims to establish a comprehensive ecosystem for nuclear medicine, strengthening capabilities in early disease detection and personalized treatment.

Who Are The Prominent Global Companies Shaping The Nuclear Medicine Market Landscape?

Major companies operating in the nuclear medicine market are Bracco Imaging S.P.A., Lantheus Medical Imaging Inc., NTP Radioisotopes SOC Ltd., Eckert & Ziegler Group, Jubilant Pharma LLC, Australian Nuclear Science & Technology Organisation, Cardinal Health Inc., GE Healthcare Technologies Inc., Curium Pharma, Advanced Accelerator Applications USA Inc., Nordion Inc., The Institute for Radioelements, Eczacibasi-Monrol Nuclear Products Co., Siemens Healthineers AG, Cambridge Isotope Laboratories Inc., Bayer AG, Triad Isotopes Inc., Mallinckrodt Pharmaceuticals plc, PharmaLogic Holdings Corp., Institute of Isotopes Co. Ltd., Sinotau Pharmaceuticals Limited, Isotopia Molecular Imaging Limited, SHINE Medical Technologies Inc., JSC Isotope Inc., NorthStar Medical Radioisotopes LLC, Global Medical Solutions LLC

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-global-market-report

Which Region Is Projected To Lead The Nuclear Medicine Market During The Forecast Period?

North America was the largest region in the nuclear medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nuclear medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Nuclear Medicine Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7485&type=smp

Browse Through More Reports Similar to the Global Nuclear Medicine Market 2026, By The Business Research Company

Medical Irradiation Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-irradiation-global-market-report

Nuclear Medicine Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-diagnostics-global-market-report

Nuclear Medicine Radioisotopes Market Report 2026

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-radioisotopes-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model